Clinical and molecular characterization of a near fatal case of human babesiosis in Austria

Journal of Travel Medicine

Volumn 17, Issue 6, 2010, Pages 416-418

  Ramharter, Michael ^a   Walochnik, Julia ^a   Lagler, Heimo ^a   Winkler, Stefan ^a   Wernsdorfer, Walther H ^a   Stoiser, Brigitte ^a   Graninger, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; QUININE;

ADULT; ANAMNESIS; ANURIA; ARTICLE; AUSTRIA; BABESIA MICROTI; BABESIOSIS; CASE REPORT; DETERIORATION; DIAGNOSTIC ERROR; FATALITY; HEMOLYSIS; HUMAN; INTENSIVE CARE; MALARIA FALCIPARUM; MALE; NICARAGUA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SHOCK; TRAVEL;

AUSTRIA; BABESIA MICROTI; BABESIOSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; NICARAGUA; POLYMERASE CHAIN REACTION; TRAVEL; TREATMENT OUTCOME;

EID: 78349233455     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2010.00446.x     Document Type: Article

References (9)

1. Health information for travelers to Nicaragua. Atlanta, Centers for Disease Control and Prevention. Available at:. (Accessed 2010 Jan 14).
2. Wongsrichanalai C, Barcus MJ, Muth S, et al., A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 2007; 77 (Suppl 6): 119-127.
3. Blaschitz M, Nardoslaysky-Gföller M, Kanzler M, et al., Babesia species occurring in Austrian Ixodes ricinus ticks. Appl Environ Microbiol 2008; 74: 4841-4846.
4. Nicholas KB, Nicholas HB., Jr, Deerfield II DW., GeneDoc: analysis and visualization of genetic variation. Embnet News 1997; 4: 1-4.
5. Herwaldt BL, Caccio S, Gherlinzoni F, et al., Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis 2003; 9: 942-948.
6. World Health Organization. Malaria Treatment Guidelines. 2nd Ed. Geneva: World Health Organization, 2010.
7. Krause PJ, Lepore T, Sikand VK, et al., Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med 2000; 16 343(20): 1454-1458.
8. Marley SE, Eberhard ML, Steurer FJ, et al., Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model. Antimicrob Agents Chemother 1997; 41: 91-94.
9. Ruebush TK, II, Juranek DD, Spielman A, et al., Epidemiology of human babesiosis on Nantucket Island. Am J Trop Med Hyg 1981; 30: 937-941.